Abstract
Bacterial persisters are dormant, antibiotic-tolerant cells that are phenotypic variants formed within a regularly growing, drug-susceptible population. They differ from genetically or phenotypically resistant cells in that their survival of antibiotic treatment is rooted in a dormant physiology and not in the obstruction of drug–target interactions. In this chapter, I assembled a concise overview of the formation, survival, and evolution of persisters formed by the model organism Escherichia coli. Though the formation of persister cells has stochastic aspects, it is often induced by starvation or stress as a specialized differentiation of part of the population (responsive diversification). Consequently, the phenotypic heterogeneity of persisters and regularly growing cells is commonly interpreted as a bet-hedging strategy that ensures population survival under the threat of catastrophic events and that at the same time optimizes the benefit from favorable conditions. Multiple different molecular mechanisms have been implicated in persister cell formation and can be grouped into two major classes. Non-specific mechanisms affect bacterial physiology on a global scale via, for example, alterations of energy metabolism, or are purely stochastic events that shut down cellular processes by an accidental malfunctioning (persistence as stuff happens). Conversely, specialized mechanisms directly inhibit antibiotic targets often through activation of fine-tuned molecular switches known as toxin-antitoxin modules. In addition, the repair of cellular damage caused by antibiotics is critical for the resuscitation of persister cells. A major obstacle to coherently interpreting these findings is the fragmented nature of the literature and several controversies that should be consolidated by future studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abel Zur Wiesch, P., Abel, S., Gkotzis, S., Ocampo, P., Engelstadter, J., Hinkley, T., Magnus, C., Waldor, M. K., Udekwu, K., & Cohen, T. (2015). Classic reaction kinetics can explain complex patterns of antibiotic action. Science Translational Medicine, 7, 287ra73.
Aldred, K. J., Kerns, R. J., & Osheroff, N. (2014). Mechanism of quinolone action and resistance. Biochemistry, 53, 1565–1574.
Allison, K. R., Brynildsen, M. P., & Collins, J. J. (2011). Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature, 473, 216–220.
Amato, S. M., & Brynildsen, M. P. (2015). Persister heterogeneity arising from a single metabolic stress. Current Biology, 25, 2090–2098.
Amato, S. M., Orman, M. A., & Brynildsen, M. P. (2013). Metabolic control of persister formation in Escherichia coli. Molecular Cell, 50, 475–487.
Baharoglu, Z., & Mazel, D. (2014). SOS, the formidable strategy of bacteria against aggressions. FEMS Microbiology Reviews, 38, 1126–1145.
Balaban, N. Q., Merrin, J., Chait, R., Kowalik, L., & Leibler, S. (2004). Bacterial persistence as a phenotypic switch. Science, 305, 1622–1625.
Balaban, N. Q., Gerdes, K., Lewis, K., & Mckinney, J. D. (2013). A problem of persistence: Still more questions than answers? Nature Reviews. Microbiology, 11, 587–591.
Berghoff, B. A., & Wagner, E. G. H. (2017). RNA-based regulation in type I toxin-antitoxin systems and its implication for bacterial persistence. Current Genetics, 63, 1011–1016.
Berghoff, B. A., Hoekzema, M., Aulbach, L., & Wagner, E. G. (2017). Two regulatory RNA elements affect TisB-dependent depolarization and persister formation. Molecular Microbiology, 103, 1020–1033.
Bigger, J. (1944). Treatment of staphylococcal infections with penicillin by intermittent sterilisation. The Lancet, 244, 497–500.
Blango, M. G., & Mulvey, M. A. (2010). Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrobial Agents and Chemotherapy, 54, 1855–1863.
Brauner, A., Fridman, O., Gefen, O., & Balaban, N. Q. (2016). Distinguishing between resistance, tolerance and persistence to antibiotic treatment. Nature Reviews. Microbiology, 14, 320–330.
Cho, H., Uehara, T., & Bernhardt, T. G. (2014). Beta-lactam antibiotics induce a lethal malfunctioning of the bacterial cell wall synthesis machinery. Cell, 159, 1300–1311.
Claudi, B., Spröte, P., Chirkova, A., Personnic, N., Zankl, J., Schürmann, N., Schmidt, A., & Bumann, D. (2014). Phenotypic variation of Salmonella in host tissues delays eradication by antimicrobial chemotherapy. Cell, 158, 722–733.
Conlon, B. P., Rowe, S. E., Gandt, A. B., Nuxoll, A. S., Donegan, N. P., Zalis, E. A., Clair, G., Adkins, J. N., Cheung, A. L., & Lewis, K. (2016). Persister formation in Staphylococcus aureus is associated with ATP depletion. Nature Microbiology, 1, 16051.
Corona, F., & Martinez, J. L. (2013). Phenotypic resistance to antibiotics. Antibiotics (Basel), 2, 237–255.
Dörr, T., Lewis, K., & Vulić, M. (2009). SOS response induces persistence to fluoroquinolones in Escherichia coli. PLoS Genetics, 5, e1000760.
Dörr, T., Vulic, M., & Lewis, K. (2010). Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biology, 8, e1000317.
Dörr, T., Alvarez, L., Delgado, F., Davis, B. M., Cava, F., & Waldor, M. K. (2016). A cell wall damage response mediated by a sensor kinase/response regulator pair enables beta-lactam tolerance. Proceedings of the National Academy of Sciences of the United States of America, 113, 404–409.
El Meouche, I., Siu, Y., & Dunlop, M. J. (2016). Stochastic expression of a multiple antibiotic resistance activator confers transient resistance in single cells. Scientific Reports, 6, 19538.
Fauvart, M., De Groote, V. N., & Michiels, J. (2011). Role of persister cells in chronic infections: Clinical relevance and perspectives on anti-persister therapies. Journal of Medical Microbiology, 60, 699–709.
Fisher, R. A., Gollan, B., & Helaine, S. (2017). Persistent bacterial infections and persister cells. Nature Reviews. Microbiology, 15, 453–464.
Fridman, O., Goldberg, A., Ronin, I., Shoresh, N., & Balaban, N. Q. (2014). Optimization of lag time underlies antibiotic tolerance in evolved bacterial populations. Nature, 513, 418–421.
Gohara, D. W., & Yap, M. F. (2018). Survival of the drowsiest: The hibernating 100S ribosome in bacterial stress management. Current Genetics, 64, 753–760.
Goneau, L. W., Yeoh, N. S., Macdonald, K. W., Cadieux, P. A., Burton, J. P., Razvi, H., & Reid, G. (2014). Selective target inactivation rather than global metabolic dormancy causes antibiotic tolerance in uropathogens. Antimicrobial Agents and Chemotherapy, 58, 2089–2097.
Goormaghtigh, F., & Van Melderen, L. (2016). Optimized method for measuring persistence in Escherichia coli with improved reproducibility. Methods in Molecular Biology, 1333, 43–52.
Goormaghtigh, F., Fraikin, N., Putrins, M., Hallaert, T., Hauryliuk, V., Garcia-Pino, A., Sjodin, A., Kasvandik, S., Udekwu, K., Tenson, T., Kaldalu, N., & Van Melderen, L. (2018a). Reassessing the role of type II toxin-antitoxin systems in formation of Escherichia coli type II persister cells. MBio, 9, e00640-18.
Goormaghtigh, F., Fraikin, N., Putrins, M., Hauryliuk, V., Garcia-Pino, A., Udekwu, K., Tenson, T., Kaldalu, N., & Van Melderen, L. (2018b). Reply to holden and errington, “Type II toxin-antitoxin systems and persister cells”. MBio, 9, e01838-18.
Gutierrez, A., Jain, S., Bhargava, P., Hamblin, M., Lobritz, M. A., & Collins, J. J. (2017). Understanding and sensitizing density-dependent persistence to quinolone antibiotics. Molecular Cell, 68, 1147–1154.e3.
Harms, A., Maisonneuve, E., & Gerdes, K. (2016). Mechanisms of bacterial persistence during stress and antibiotic exposure. Science, 354, aaf4268.
Harms, A., Fino, C., Sørensen, M. A., Semsey, S., & Gerdes, K. (2017). Prophages and growth dynamics confound experimental results with antibiotic-tolerant persister cells. MBio, 8, e01964-17.
Harms, A., Brodersen, D. E., Mitarai, N., & Gerdes, K. (2018). Toxins, targets, and triggers: An overview of toxin-antitoxin biology. Molecular Cell, 70, 768–784.
Hauryliuk, V., Atkinson, G. C., Murakami, K. S., Tenson, T., & Gerdes, K. (2015). Recent functional insights into the role of (p)ppGpp in bacterial physiology. Nature Reviews. Microbiology, 13, 298–309.
Helaine, S., Cheverton, A. M., Watson, K. G., Faure, L. M., Matthews, S. A., & Holden, D. W. (2014). Internalization of Salmonella by macrophages induces formation of nonreplicating persisters. Science, 343, 204–208.
Hofsteenge, N., Van Nimwegen, E., & Silander, O. K. (2013). Quantitative analysis of persister fractions suggests different mechanisms of formation among environmental isolates of E. coli. BMC Microbiology, 13, 25.
Joers, A., Kaldalu, N., & Tenson, T. (2010). The frequency of persisters in Escherichia coli reflects the kinetics of awakening from dormancy. Journal of Bacteriology, 192, 3379–3384.
Johnson, P. J., & Levin, B. R. (2013). Pharmacodynamics, population dynamics, and the evolution of persistence in Staphylococcus aureus. PLoS Genetics, 9, e1003123.
Kaldalu, N., Hauryliuk, V., & Tenson, T. (2016). Persisters-as elusive as ever. Applied Microbiology and Biotechnology, 100, 6545–6553.
Keren, I., Kaldalu, N., Spoering, A., Wang, Y., & Lewis, K. (2004a). Persister cells and tolerance to antimicrobials. FEMS Microbiology Letters, 230, 13–18.
Keren, I., Shah, D., Spoering, A., Kaldalu, N., & Lewis, K. (2004b). Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. Journal of Bacteriology, 186, 8172–8180.
Keren, I., Wu, Y., Inocencio, J., Mulcahy, L. R., & Lewis, K. (2013). Killing by bactericidal antibiotics does not depend on reactive oxygen species. Science, 339, 1213–1216.
Kohanski, M. A., Dwyer, D. J., & Collins, J. J. (2010). How antibiotics kill bacteria: From targets to networks. Nature Reviews. Microbiology, 8, 423–435.
Kotte, O., Volkmer, B., Radzikowski, J. L., & Heinemann, M. (2014). Phenotypic bistability in Escherichia coli’s central carbon metabolism. Molecular Systems Biology, 10, 736.
Krause, K. M., Serio, A. W., Kane, T. R., & Connolly, L. E. (2016). Aminoglycosides: An overview. Cold Spring Harbor Perspectives in Medicine, 6, a027029.
Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K., Wertheim, H. F., Sumpradit, N., Vlieghe, E., Hara, G. L., Gould, I. M., Goossens, H., Greko, C., SO, A. D., Bigdeli, M., Tomson, G., Woodhouse, W., Ombaka, E., Peralta, A. Q., Qamar, F. N., Mir, F., Kariuki, S., Bhutta, Z. A., Coates, A., Bergstrom, R., Wright, G. D., Brown, E. D., & Cars, O. (2013). Antibiotic resistance-the need for global solutions. The Lancet Infectious Diseases, 13, 1057–1098.
Lee, A. J., Wang, S., Meredith, H. R., Zhuang, B., Dai, Z., & You, L. (2018). Robust, linear correlations between growth rates and beta-lactam-mediated lysis rates. Proceedings of the National Academy of Sciences of the United States of America, 115, 4069–4074.
Levin, B. R., & Rozen, D. E. (2006). Non-inherited antibiotic resistance. Nature Reviews. Microbiology, 4, 556–562.
Levin, B. R., Concepcion-Acevedo, J., & Udekwu, K. I. (2014). Persistence: A copacetic and parsimonious hypothesis for the existence of non-inherited resistance to antibiotics. Current Opinion in Microbiology, 21, 18–21.
Lewis, K. (2005). Persister cells and the riddle of biofilm survival. Biochemistry (Mosc), 70, 267–274.
Lewis, K. (2010). Persister cells. Annual Review of Microbiology, 64, 357–372.
Li, Y., & Zhang, Y. (2007). PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli. Antimicrobial Agents and Chemotherapy, 51, 2092–2099.
Li, J., Ji, L., Shi, W., Xie, J., & Zhang, Y. (2013). Trans-translation mediates tolerance to multiple antibiotics and stresses in Escherichia coli. The Journal of Antimicrobial Chemotherapy, 68, 2477–2481.
Liu, Y., & Imlay, J. A. (2013). Cell death from antibiotics without the involvement of reactive oxygen species. Science, 339, 1210–1213.
Luidalepp, H., Joers, A., Kaldalu, N., & Tenson, T. (2011). Age of inoculum strongly influences persister frequency and can mask effects of mutations implicated in altered persistence. Journal of Bacteriology, 193, 3598–3605.
Ma, C., Sim, S., Shi, W., Du, L., Xing, D., & Zhang, Y. (2010). Energy production genes sucB and ubiF are involved in persister survival and tolerance to multiple antibiotics and stresses in Escherichia coli. FEMS Microbiology Letters, 303, 33–40.
Maisonneuve, E., & Gerdes, K. (2014). Molecular mechanisms underlying bacterial persisters. Cell, 157, 539–548.
McKay, S. L., & Portnoy, D. A. (2015). Ribosome hibernation facilitates tolerance of stationary-phase bacteria to aminoglycosides. Antimicrobial Agents and Chemotherapy, 59, 6992–6999.
Michiels, J. E., Van Den Bergh, B., Verstraeten, N., Fauvart, M., & Michiels, J. (2016). In vitro emergence of high persistence upon periodic aminoglycoside challenge in the ESKAPE pathogens. Antimicrobial Agents and Chemotherapy, 60, 4630–4637.
Miller, C., Thomsen, L. E., Gaggero, C., Mosseri, R., Ingmer, H., & Cohen, S. N. (2004). SOS response induction by ß-lactams and bacterial defense against antibiotic lethality. Science, 305, 1629–1631.
Molina-Quiroz, R. C., Lazinski, D. W., Camilli, A., & Levy, S. B. (2016). Transposon-sequencing analysis unveils novel genes involved in the generation of persister cells in uropathogenic Escherichia coli. Antimicrobial Agents and Chemotherapy, 60, 6907–6910.
Mordukhova, E. A., & Pan, J. G. (2014). Stabilization of homoserine-O-succinyltransferase (MetA) decreases the frequency of persisters in Escherichia coli under stressful conditions. PLoS One, 9, e110504.
Moyed, H. S., & Bertrand, K. P. (1983). hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. Journal of Bacteriology, 155, 768–775.
Neidhardt, F. C. (2006). Apples, oranges and unknown fruit. Nature Reviews. Microbiology, 4, 876.
Nguyen, D., Joshi-Datar, A., Lepine, F., Bauerle, E., Olakanmi, O., Beer, K., Mckay, G., Siehnel, R., Schafhauser, J., Wang, Y., Britigan, B. E., & Singh, P. K. (2011). Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria. Science, 334, 982–986.
Ocampo, P. S., Lazar, V., Papp, B., Arnoldini, M., Abel Zur Wiesch, P., Busa-Fekete, R., Fekete, G., Pal, C., Ackermann, M., & Bonhoeffer, S. (2014). Antagonism between bacteriostatic and bactericidal antibiotics is prevalent. Antimicrobial Agents and Chemotherapy, 58, 4573–4582.
Orman, M. A., & Brynildsen, M. P. (2013). Dormancy is not necessary or sufficient for bacterial persistence. Antimicrobial Agents and Chemotherapy, 57, 3230–3239.
Pennington, J. M., & Rosenberg, S. M. (2007). Spontaneous DNA breakage in single living Escherichia coli cells. Nature Genetics, 39, 797–802.
Pu, Y., Zhao, Z., Li, Y., Zou, J., Ma, Q., Zhao, Y., Ke, Y., Zhu, Y., Chen, H., Baker, M. A., Ge, H., Sun, Y., Xie, X. S., & BAI, F. (2016). Enhanced efflux activity facilitates drug tolerance in dormant bacterial cells. Molecular Cell, 62, 284–294.
Renggli, S., Keck, W., Jenal, U., & Ritz, D. (2013). Role of autofluorescence in flow cytometric analysis of Escherichia coli treated with bactericidal antibiotics. Journal of Bacteriology, 195, 4067–4073.
Schumacher, M. A., Balani, P., Min, J., Chinnam, N. B., Hansen, S., Vulic, M., Lewis, K., & Brennan, R. G. (2015). HipBA-promoter structures reveal the basis of heritable multidrug tolerance. Nature, 524, 59–64.
Shan, Y., Lazinski, D., Rowe, S., Camilli, A., & Lewis, K. (2015). Genetic basis of persister tolerance to aminoglycosides in Escherichia coli. MBio, 6, e00078-15.
Shan, Y., Brown Gandt, A., Rowe, S. E., Deisinger, J. P., Conlon, B. P., & Lewis, K. (2017). ATP-dependent persister formation in Escherichia coli. MBio, 8, e02267-16.
Spoering, A. L., Vulic, M., & Lewis, K. (2006). GlpD and PlsB participate in persister cell formation in Escherichia coli. Journal of Bacteriology, 188, 5136–5144.
Stepanyan, K., Wenseleers, T., Duenez-Guzman, E. A., Muratori, F., Van Den Bergh, B., Verstraeten, N., De Meester, L., Verstrepen, K. J., Fauvart, M., & Michiels, J. (2015). Fitness trade-offs explain low levels of persister cells in the opportunistic pathogen Pseudomonas aeruginosa. Molecular Ecology, 24, 1572–1583.
Stewart, B., & Rozen, D. E. (2012). Genetic variation for antibiotic persistence in Escherichia coli. Evolution, 66, 933–939.
Theodore, A., Lewis, K., & Vulic, M. (2013). Tolerance of Escherichia coli to fluoroquinolone antibiotics depends on specific components of the SOS response pathway. Genetics, 195, 1265–1276.
Van Den Bergh, B., Michiels, J. E., Wenseleers, T., Windels, E. M., Boer, P. V., Kestemont, D., De Meester, L., Verstrepen, K. J., Verstraeten, N., Fauvart, M., & Michiels, J. (2016). Frequency of antibiotic application drives rapid evolutionary adaptation of Escherichia coli persistence. Nature Microbiology, 1, 16020.
Van Den Bergh, B., Fauvart, M., & Michiels, J. (2017). Formation, physiology, ecology, evolution and clinical importance of bacterial persisters. FEMS Microbiology Reviews, 41, 219–251.
Van Melderen, L., & Wood, T. K. (2017). Commentary: What is the link between stringent response, endoribonuclease encoding type II toxin-antitoxin systems and persistence? Frontiers in Microbiology, 8, 191.
Vazquez-Laslop, N., Lee, H., & Neyfakh, A. A. (2006). Increased persistence in Escherichia coli caused by controlled expression of toxins or other unrelated proteins. Journal of Bacteriology, 188, 3494–3497.
Veening, J. W., Smits, W. K., & Kuipers, O. P. (2008). Bistability, epigenetics, and bet-hedging in bacteria. Annual Review of Microbiology, 62, 193–210.
Vega, N. M., Allison, K. R., Khalil, A. S., & Collins, J. J. (2012). Signaling-mediated bacterial persister formation. Nature Chemical Biology, 8, 431–433.
Verstraeten, N., Knapen, W. J., Kint, C. I., Liebens, V., Van Den Bergh, B., Dewachter, L., Michiels, J. E., Fu, Q., David, C. C., Fierro, A. C., Marchal, K., Beirlant, J., Versees, W., Hofkens, J., Jansen, M., Fauvart, M., & Michiels, J. (2015). Obg and membrane depolarization are part of a microbial bet-hedging strategy that leads to antibiotic tolerance. Molecular Cell, 59, 9–21.
Völzing, K. G., & Brynildsen, M. P. (2015). Stationary-phase persisters to ofloxacin sustain DNA damage and require repair systems only during recovery. MBio, 6, e00731–e00715.
Wakamoto, Y., Dhar, N., Chait, R., Schneider, K., Signorino-Gelo, F., Leibler, S., & Mckinney, J. D. (2013). Dynamic persistence of antibiotic-stressed mycobacteria. Science, 339, 91–95.
Wilmaerts, D., Bayoumi, M., Dewachter, L., Knapen, W., Mika, J. T., Hofkens, J., Dedecker, P., Maglia, G., Verstraeten, N., & Michiels, J. (2018). The persistence-inducing toxin HokB forms dynamic pores that cause ATP leakage. MBio, 9, e00744-18.
Wiuff, C., & Andersson, D. I. (2007). Antibiotic treatment in vitro of phenotypically tolerant bacterial populations. The Journal of Antimicrobial Chemotherapy, 59, 254–263.
Wood, T. K., Knabel, S. J., & Kwan, B. W. (2013). Bacterial persister cell formation and dormancy. Applied and Environmental Microbiology, 79, 7116–7121.
Yang, J. H., Bening, S. C., & Collins, J. J. (2017). Antibiotic efficacy-context matters. Current Opinion in Microbiology, 39, 73–80.
Acknowledgements
The author is grateful to Prof. Kenn Gerdes, Prof. Urs Jenal, Dr. Szabolcs Semsey, and Dr. Pablo Manfredi for stimulating discussions about the elusive nature of genetically encoded antibiotic tolerance. This work was supported by Swiss National Science Foundation (SNSF) Ambizione Fellowship PZ00P3_180085.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Harms, A. (2019). The Biology of Persister Cells in Escherichia coli . In: Lewis, K. (eds) Persister Cells and Infectious Disease. Springer, Cham. https://doi.org/10.1007/978-3-030-25241-0_3
Download citation
DOI: https://doi.org/10.1007/978-3-030-25241-0_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-25240-3
Online ISBN: 978-3-030-25241-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)